Aligos Therapeutics (ALGS) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-4
-2.42
-0.83
0.75

Details

Expected EPS
-2.156667
Actual EPS
-3.07
Surprise EPS
-0.91
Surprise Percent
-42.35%

Description

⁨Aligos Therapeutics⁩ (⁦ALGS⁩) has reported earnings of ⁦-3.07⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts